According to Lineage Cell Therapeutics 's latest financial reports the company's current revenue (TTM) is $8.94 M. In 2022 the company made a revenue of $14.7 M an increase over the years 2021 revenue that were of $3.89 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $8.94 M | -39.16% |
2022 | $14.7 M | 277.39% |
2021 | $3.89 M | 404.01% |
2020 | $0.77 M | -47.7% |
2019 | $1.47 M | 4.38% |
2018 | $1.41 M | -20.98% |
2017 | $1.79 M | -20% |
2016 | $2.24 M | -11.53% |
2015 | $2.53 M | 30.17% |
2014 | $1.94 M | -32.01% |
2013 | $2.86 M | 1539.24% |
2012 | $0.17 M | -96.03% |
2011 | $4.39 M | 19.42% |
2010 | $3.68 M | 91.29% |
2009 | $1.92 M | 28.02% |
2008 | $1.5 M | 43.75% |
2007 | $1.04 M | -9.97% |
2006 | $1.16 M | 28.66% |
2005 | $0.9 M | 31.21% |
2004 | $0.68 M | 23.71% |
2003 | $0.55 M | 43.77% |
2002 | $0.38 M | 154.76% |
2001 | $0.15 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |